Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02142829 · ClinicalTrials.gov registry record · Phase 4
Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball
A Phase 4 study of Obesity, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT02142829: Completed Phase 4 study of Obesity, sponsored by Pacira Pharmaceuticals.
NCT02142829 is a Phase 4 study of Obesity that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 101 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02142829, a Phase 4 study of Obesity, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
This study was conducted to compare the effectiveness of two local pain control methods in bariatric patients by assessing the amount of postoperative pain and amount of postoperative pain medications needed. This information was used to determine which local anesthetic provided the best pain control.
Primary Outcome
The NRS was from 0 = no pain and 10 = worst pain.
Conditions Studied
Interventions
- DRUG EXPAREL
- DRUG On-Q Pain Ball
Study Locations (1)
Texas
- Bariatric Medical Institute of Texas - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
What the finished NCT02142829 record still lists
NCT02142829 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which EXPAREL is the first listed.
NCT02142829 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02142829 about?
NCT02142829 is a clinical study titled "Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball". This study was conducted to compare the effectiveness of two local pain control methods in bariatric patients by assessing the amount of postoperative pain and amount of postoperative pain medications needed. This information was used to determine which local anesthetic provided the best pain contro...
What is the current status of trial NCT02142829?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2012-11. Estimated completion is 2013-03.
What conditions does trial NCT02142829 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT02142829?
The interventions under investigation include: EXPAREL (DRUG), On-Q Pain Ball (DRUG).
Who is sponsoring clinical trial NCT02142829?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02142829 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02142829's enrollment target sits among peer trials
101 473rd of 1053 higher than 577 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
RECRUITING · Phase 4
-
Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
RECRUITING · Phase 4
-
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
RECRUITING · Phase 4
-
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
RECRUITING · Phase 4
-
Fibrosis Lessens After Metabolic Surgery
RECRUITING · Phase 4
-
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia